PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Flecainide acetate - Arrhythmias

PAD Profile : Flecainide acetate - Arrhythmias

Keywords :
supraventricular arrhythmias, ventricular arrhythmias
Brand Names Include :
Tambocor

Traffic Light Status

Status 1 of 2.

Status :
Blue
Important
Formulations :
  • Tablets
Important Information :
Specialist initiation and at least one month supply before transfer to primary care
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Red
Important
Formulations :
  • Injection
Important Information :
Unlicensed. For use or advice by cardiology consultants only.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Flecainide has been considered by the PCN and has been assigned a BLUE traffic light status. NOTE - the branded product, Tambocor, was considered BLACK at the PCN in May 2017.
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN supported the attached updated Amber* Information Sheet.

Associated BNF Codes

02. Cardiovascular System
02.03.02. Drugs for arrhythmias
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More